ULTRASONIC APPARATUS DETERMINING CARDIAC

Brand Owner (click to sort) Address Description
ADBF NEOPROBE CORPORATION 425 Metro Place North Suite 300 Columbus OH 430171367 ultrasonic apparatus for determining cardiac output and blood flow;
CARDIOSONIX NEOPROBE CORPORATION 425 Metro Place North Suite 300 Columbus OH 430171367 ULTRASONIC APPARATUS FOR DETERMINING CARDIAC OUTPUT AND BLOOD FLOW;
NEUROSONIX NEOPROBE CORPORATION 425 Metro Place North Suite 300 Columbus OH 430171367 ULTRASONIC APPARATUS FOR DETERMINING CARDIAC OUTPUT AND BLOOD FLOW;
QUANTIX NAVIDEA BIOPHARMACEUTICALS, INC. Suite 240 4995 Bradenton Avenue Dublin OH 43017 ULTRASONIC APPARATUS FOR DETERMINING CARDIAC OUTPUT AND BLOOD FLOW;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method and apparatus delivering therapy in an implantable medical device that includes sensing a first cardiac signal and detecting cardiac events via a first electrode configuration, determining the presence of an episode requiring therapy in response to the detected cardiac events, sensing a second cardiac signal via a second electrode configuration, comparing, in response to an episode being present, portions of the second cardiac signal corresponding to the detected cardiac events with a predetermined template, and determining whether to deliver therapy in response to the comparing.